P

Assignee

SOMALOGIC INC

US59 patents

Top patents by PatentIndex Score

US7947447B2May 24, 2011

Method for generating aptamers with improved off-rates

SOMALOGIC INC90 citations98
US6376190B1Apr 23, 2002

Modified SELEX processes without purified protein

SOMALOGIC INC169 citations98
US6291184B1Sep 18, 2001

Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex

SOMALOGIC INC116 citations98
US10316321B2Jun 11, 2019

Method for generating aptamers with improved off-rates

SOMALOGIC INC38 citations97
US7964356B2Jun 21, 2011

Method for generating aptamers with improved off-rates

SOMALOGIC INC87 citations97
US6544776B1Apr 8, 2003

Nucleic acid ligand diagnostic biochip

SOMALOGIC INC141 citations97
US6503715B1Jan 7, 2003

Nucleic acid ligand diagnostic biochip

SOMALOGIC INC94 citations97
US6458543B1Oct 1, 2002

Nucleic acid ligand diagnostic biochip

SOMALOGIC INC138 citations97
US6242246B1Jun 5, 2001

Nucleic acid ligand diagnostic Biochip

SOMALOGIC INC230 citations97
US10221421B2Mar 5, 2019

Post-selec modification methods

SOMALOGIC INC39 citations96
US7855054B2Dec 21, 2010

Multiplexed analyses of test samples

SOMALOGIC INC123 citations96
US10221207B2Mar 5, 2019

5-position modified pyrimidines and their use

SOMALOGIC INC39 citations95
US9163056B2Oct 20, 2015

5-position modified pyrimidines and their use

SOMALOGIC INC42 citations95
US6482594B2Nov 19, 2002

Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands

SOMALOGIC INC57 citations95
US6458539B1Oct 1, 2002

Photoselection of nucleic acid ligands

SOMALOGIC INC132 citations95
US9404919B2Aug 2, 2016

Multiplexed analyses of test samples

SOMALOGIC INC51 citations93
US10239908B2Mar 26, 2019

Cytidine-5-carboxamide modified nucleotide compositions and methods related thereto

SOMALOGIC INC37 citations92
US9938314B2Apr 10, 2018

Cytidine-5-carboxamide modified nucleotide compositions and methods related thereto

SOMALOGIC INC38 citations92
US9382533B2Jul 5, 2016

Method for generating aptamers with improved off-rates

SOMALOGIC INC16 citations92
US7709192B2May 4, 2010

Nucleic acid ligand diagnostic biochip

SOMALOGIC INC12 citations92
US7629151B2Dec 8, 2009

Method and apparatus for the automated generation of nucleic acid ligands

SOMALOGIC INC38 citations92
US6730482B2May 4, 2004

Modified SELEX processes without purified protein

SOMALOGIC INC32 citations92
US6716580B2Apr 6, 2004

Method for the automated generation of nucleic acid ligands

SOMALOGIC INC45 citations92
US6569620B1May 27, 2003

Method for the automated generation of nucleic acid ligands

SOMALOGIC INC46 citations92
US6506887B1Jan 14, 2003

Conditional-selex

SOMALOGIC INC34 citations92
US10392621B2Aug 27, 2019

Multiaptamer target detection

SOMALOGIC INC36 citations91
US9926566B2Mar 27, 2018

Multiaptamer target detection

SOMALOGIC INC38 citations91
US9701967B2Jul 11, 2017

Aptamers to PDGF and VEGF and their use in treating PDGF and VEGF mediated conditions

SOMALOGIC INC4 citations82
US9410156B2Aug 9, 2016

Aptamers to PDGF and VEGF and their use in treating PDGF and VEGF mediated conditions

SOMALOGIC INC4 citations82
US9081010B2Jul 14, 2015

Aptamers for clostridium difficile diagnostics

SOMALOGIC INC5 citations81
US10481155B2Nov 19, 2019

Proteomic assay using quantum sensors

SOMALOGIC INC5 citations80
US9423403B2Aug 23, 2016

Chronic obstructive pulmonary disease (COPD) biomarkers and uses thereof

SOMALOGIC INC7 citations79
US9103837B2Aug 11, 2015

Chronic obstructive pulmonary disease (COPD) biomarkers and uses thereof

SOMALOGIC INC9 citations79
US11111495B2Sep 7, 2021

Method for generating aptamers with improved off-rates

SOMALOGIC INC2 citations73
US6706482B2Mar 16, 2004

Conditional-selex

SOMALOGIC INC11 citations73
US10544419B2Jan 28, 2020

PDGF and VEGF aptamers having improved stability and their use in treating PDGF and VEGF mediated diseases and disorders

SOMALOGIC INC1 citations71
US9994857B2Jun 12, 2018

PDGF and VEGF aptamers having improved stability and their use in treating PDGF and VEGF mediated diseases and disorders

SOMALOGIC INC2 citations71
US9695424B2Jul 4, 2017

PDGF and VEGF aptamers having improved stability and their use in treating PDGF and VEGF mediated diseases and disorders

SOMALOGIC INC3 citations71
US11249080B2Feb 15, 2022

Proteomic assay using quantum sensors

SOMALOGIC INC2 citations69
US9316647B2Apr 19, 2016

Aptamers and diagnostic methods for detecting the EGF receptor

SOMALOGIC INC4 citations69
US10359435B2Jul 23, 2019

Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) biomarkers and uses thereof

SOMALOGIC INC3 citations68
US9945875B2Apr 17, 2018

Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) biomarkers and uses thereof

SOMALOGIC INC2 citations68
US9612248B2Apr 4, 2017

Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) biomarkers and uses thereof

SOMALOGIC INC4 citations68
US10670611B2Jun 2, 2020

Cardiovascular risk event prediction and uses thereof

SOMALOGIC INC3 citations67
US11208663B2Dec 28, 2021

Post-selex modification methods

SOMALOGIC INC0 citations61
US10927380B2Feb 23, 2021

Oligonucleotides comprising modified nucleosides

SOMALOGIC INC0 citations59
US11041866B2Jun 22, 2021

Pancreatic cancer biomarkers and uses thereof

SOMALOGIC INC0 citations55
US10808251B2Oct 20, 2020

Nucleic acid compounds for binding growth differentiation factor 11

SOMALOGIC INC0 citations50
US10648972B2May 12, 2020

Multiplexed analyses of test samples

SOMALOGIC INC0 citations50
US10538771B2Jan 21, 2020

Compositions and methods for detecting microorganisms

SOMALOGIC INC0 citations50

Showing the top 50 of 59 patents by PatentIndex Score.